[HTML][HTML] Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

BC Procter, C Ross, V Pickard, E Smith… - Reviews in …, 2020 - imrpress.com
There is an emergency need for early ambulatory treatment of Coronavirus Disease 2019
(COVID-19) in acutely ill patients in an attempt to reduce disease progression and the risks …

Early ambulatory multidrug therapy reduces hospitalization and death in high-risk patients with SARS-CoV-2 (COVID-19)

B Procter, C Ross, V Pickard, E Smith, C Hanson… - Authorea …, 2021 - authorea.com
Background. There is an emergency need for early ambulatory treatment of COVID-19 in
acutely ill patients in an attempt to reduce disease progression and the risks of …

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

PA McCullough, PE Alexander… - Reviews in …, 2020 - scholarlycommons.henryford.com
The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness,
hospitalizations, and death. The complex and multifaceted pathophysiology of life …

[HTML][HTML] Clinical management of adult coronavirus infection disease 2019 (COVID-19) positive in the setting of low and medium intensity of care: a short practical …

A Pennica, G Conforti, F Falangone… - SN Comprehensive …, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-2019) is a viral infection which is rapidly
spreading on a global scale and causing a severe acute respiratory syndrome that affects …

[HTML][HTML] COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations

GT Flaherty, P Hession, CH Liew, BCW Lim… - Tropical diseases, travel …, 2020 - Springer
Background A high burden of severe disease and death from the coronavirus disease 2019
(COVID-19) has been consistently observed in older patients, especially those with pre …

[HTML][HTML] Pharmacological treatment of patients with mild to moderate COVID-19: a comprehensive review

RB Bestetti, R Furlan-Daniel, VMR Silva - International Journal of …, 2021 - mdpi.com
Mild to moderate COVID-19 can be found in about 80% of patients. Although mortality is low,
mild to moderate COVID-19 may progress to severe or even critical stages in about one …

Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents

PE Alexander, R Armstrong, G Fareed, J Lotus… - Medical hypotheses, 2021 - Elsevier
The outbreak of COVID-19 from severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread all over the world with tremendous morbidity and mortality in the elderly …

[HTML][HTML] Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi …

N Chandiwana, C Kruger, H Johnstone… - …, 2022 - thelancet.com
Background This exploratory study investigated four repurposed anti-infective drug
regimens in outpatients with COVID-19. Methods This phase 2, single centre, randomised …

[HTML][HTML] A home-treatment algorithm based on anti-inflammatory drugs to prevent hospitalization of patients with early COVID-19: A matched-cohort study (Cover 2)

E Consolaro, F Suter, N Rubis, S Pedroni… - Frontiers in …, 2022 - frontiersin.org
Background and Aim: While considerable success has been achieved in the management of
patients hospitalised with severe coronavirus disease 2019 (COVID-19), far less progress …

[HTML][HTML] COVID-19 patient management in outpatient setting: a population-based study from Southern Italy

S Crisafulli, V Ientile, L L'Abbate, A Fontana… - Journal of clinical …, 2021 - mdpi.com
Evidence on treatments for early-stage COVID-19 in outpatient setting is sparse. We
explored the pattern of use of drugs prescribed for COVID-19 outpatients' management in …